(Q56994404)

https://api.crossref.org/works/10.1517%2F14712590802571928

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

An HIV vaccine--evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

A therapeutic HIV vaccine: how good is good enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Human genes that limit AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The influence of HLA genotype on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Considering genetic profiles in functional studies of immune responsiveness to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Interleukin-10 determines viral clearance or persistence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

NK cells in HIV infection: paradigm for protection or targets for ambush

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Post-infection immunodeficiency virus control by neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Hitting HIV where it hurts: an alternative approach to HIV vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731764

Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A Possible Role in the Resistance to HIV of HIV‐Exposed Seronegative Individuals

2 November 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

Foxp3+ regulatory T cells in antiretroviral-naive HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802571928

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

21 January 2018

1 reference

12 December 2020

Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection

1 reference

12 December 2020

Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes

1 reference

12 December 2020

Retrovirus meeting. Back-to-basics push as HIV prevention struggles

1 reference

12 December 2020

A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef

1 reference

12 December 2020

Estimating the benefit of an HIV-1 vaccine that reduces viral load set point

1 reference

12 December 2020

Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression

1 reference

12 December 2020

Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function

1 reference

12 December 2020

HIV vaccine failure prompts Merck to halt trial

1 reference

12 December 2020

Opposite Effects of IL-10 on the Ability of Dendritic Cells and Macrophages to Replicate Primary CXCR4-Dependent HIV-1 Strains

1 reference

12 December 2020